Death and cardiovascular events after bacteriuria among adult women with chronic kidney disease

被引:0
|
作者
Dhanyamraju, Susmitha [1 ]
Foltzer, Michael A. [2 ]
Tang, Xiaoqin [3 ]
Kirchner, H. Lester [4 ]
Perkins, Robert M. [5 ,6 ]
机构
[1] Geisinger Med Ctr, Dept Nephrol, Danville, PA 17822 USA
[2] Geisinger Med Ctr, Dept Infect Dis, Danville, PA 17822 USA
[3] Ctr Hlth Res, Danville, PA USA
[4] Geisinger Med Ctr, Div Med, Danville, PA 17822 USA
[5] Bassett Healthcare, Dept Nephrol, One Atwell Dr, Cooperstown, NY 13326 USA
[6] Bassett Res Inst, Bassett Med Ctr, Cooperstown, NY USA
关键词
bacteriuria; cardiovascular; chronic kidney disease; death; mortality;
D O I
10.2147/IJNRD.S37061
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The impact of bacteriuria on mortality and cardiovascular risk has not been previously reported for patients with chronic kidney disease (CKD). Objective: To assess the relationship between outpatient episodes of bacteriuria and mortality and cardiovascular risk among women with CKD. Design: Retrospective cohort study using an electronic health database from an integrated healthcare system in central Pennsylvania. Subjects: Adult women with CKD receiving primary care at Geisinger Health System between January 1, 2004 and December 31, 2009 were eligible, and were followed through December 31, 2010 for study outcomes. Main measures: The study exposure was bacteriuria, defined as an outpatient urine culture with bacterial growth of 10(4) cfu/mL. Treatment history (antibiotic prescription within 90 days) was identified. Study outcomes were death and the composite of hospitalization for myocardial infarction, congestive heart failure, or stroke. Multivariate-adjusted Cox models incorporated all bacteriuria episodes and antibiotic prescriptions in time-dependent fashion (in addition to other covariates) to account for the cumulative impact of infections, treatment, and hospitalization during follow-up. Key results: 6807 women were followed for a median (interquartile range) of 5.2 (3.4, 5.9) years. In adjusted models, each untreated bacteriuria episode was associated with an increased risk of death (hazard ratio [HR] 1.56, 95% CI 1.35-1.81) and the composite cardiovascular outcome (HR 1.32, 95% CI 1.05-1.65); treated episodes were not associated with an increased risk of death or cardiovascular events. Conclusion: Among female patients with CKD, untreated bacteriuria occurring in the outpatient setting is associated with an increased risk of death and cardiovascular morbidity.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 50 条
  • [1] Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    Go, AS
    Chertow, GM
    Fan, DJ
    McCulloch, CE
    Hsu, CY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13): : 1296 - 1305
  • [2] CARDIOVASCULAR EVENTS AND DEATH IN PEOPLE LIVING WITH CHRONIC KIDNEY DISEASE
    Cuthbertson, L.
    Cash, E.
    Prentice, L.
    Black, A.
    Burgess, J.
    Macintyre, K.
    Saunder, T.
    Kitsos, A.
    Jose, K.
    Raj, R.
    Mckercher, C. E.
    Radford, J.
    Jose, M.
    [J]. NEPHROLOGY, 2020, 25 : 46 - 46
  • [3] Cardiovascular events and death in Japanese patients with chronic kidney disease
    Tanaka, Kenichi
    Watanabe, Tsuyoshi
    Takeuchi, Ayano
    Ohashi, Yasuo
    Nitta, Kosaku
    Akizawa, Tadao
    Matsuo, Seiichi
    Imai, Enyu
    Makino, Hirofumi
    Hishida, Akira
    [J]. KIDNEY INTERNATIONAL, 2017, 91 (01) : 227 - 234
  • [4] Risk of End-Stage Renal Disease and Death After Cardiovascular Events in Chronic Kidney Disease
    Sud, Maneesh
    Tangri, Navdeep
    Pintilie, Melania
    Levey, Andrew S.
    Naimark, David
    [J]. CIRCULATION, 2014, 130 (06) : 458 - +
  • [5] Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
    Borg, Rikke
    Kriegbaum, Margit
    Grand, Mia Klinten
    Lind, Bent
    Andersen, Christen Lykkegaard
    Persson, Frederik
    [J]. BMC PRIMARY CARE, 2023, 24 (01):
  • [6] Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
    Rikke Borg
    Margit Kriegbaum
    Mia Klinten Grand
    Bent Lind
    Christen Lykkegaard Andersen
    Frederik Persson
    [J]. BMC Primary Care, 24
  • [7] Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
    Demetria Hubbard
    Lisandro D. Colantonio
    Robert S. Rosenson
    Todd M. Brown
    Elizabeth A. Jackson
    Lei Huang
    Kate K. Orroth
    Stephanie Reading
    Mark Woodward
    Vera Bittner
    Orlando M. Gutierrez
    Monika M. Safford
    Michael E. Farkouh
    Paul Muntner
    [J]. Cardiovascular Diabetology, 20
  • [8] Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
    Hubbard, Demetria
    Colantonio, Lisandro D.
    Rosenson, Robert S.
    Brown, Todd M.
    Jackson, Elizabeth A.
    Huang, Lei
    Orroth, Kate K.
    Reading, Stephanie
    Woodward, Mark
    Bittner, Vera
    Gutierrez, Orlando M.
    Safford, Monika M.
    Farkouh, Michael E.
    Muntner, Paul
    [J]. CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [9] Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease
    Ravani, P.
    Tripepi, G.
    Pecchini, P.
    Mallamaci, F.
    Malberti, F.
    Zoccali, C.
    [J]. KIDNEY INTERNATIONAL, 2008, 73 (01) : 95 - 101
  • [10] Contemporary Population-based Evaluation of Chronic Kidney Disease With Cardiovascular Events and Death
    Go, Alan S.
    Yang, Jingrong
    Rana, Jamal S.
    Cabrera, Claudia S.
    Stefansson, Bergur
    Greasley, Peter J.
    Tan, Thida C.
    [J]. CIRCULATION, 2017, 136